Have your own idea? Try our Stock Screener
U.S. Biotech Industry Analysis
UpdatedJul 16, 2025
DataAggregated Company Financials
Companies562
- 7D0.4%
- 3M8.2%
- 1Y-14.8%
- YTD-0.9%
Over the last 7 days, the Biotech industry has remained flat, although notably BeOne Medicines gained 10%. As for the longer term, the industry has declined 15% in the last year. Earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 16 Jul 2025 | US$985.4b | US$155.7b | -US$23,407,231,049.90 | 17x | -42.1x | 6.3x |
| Fri, 13 Jun 2025 | US$952.7b | US$155.9b | -US$23,953,257,844.78 | 16.4x | -39.8x | 6.1x |
| Sun, 11 May 2025 | US$861.2b | US$154.9b | -US$24,538,327,634.73 | 16.7x | -35.1x | 5.6x |
| Tue, 08 Apr 2025 | US$735.7b | US$118.6b | -US$37,003,812,363.33 | 20.2x | -19.9x | 6.2x |
| Thu, 06 Mar 2025 | US$833.3b | US$119.0b | -US$37,174,684,124.22 | 16.7x | -22.4x | 7x |
| Sat, 01 Feb 2025 | US$998.3b | US$149.5b | -US$26,306,804,829.57 | 17.2x | -37.9x | 6.7x |
| Mon, 30 Dec 2024 | US$977.8b | US$149.9b | -US$26,372,711,577.30 | 16.2x | -37.1x | 6.5x |
| Wed, 27 Nov 2024 | US$1.0t | US$150.0b | -US$26,586,070,085.45 | 16.4x | -38.7x | 6.9x |
| Fri, 25 Oct 2024 | US$884.2b | US$113.1b | -US$36,026,588,945.48 | 20.7x | -24.5x | 7.8x |
| Sun, 22 Sep 2024 | US$920.0b | US$113.2b | -US$35,985,348,157.41 | 21.9x | -25.6x | 8.1x |
| Tue, 20 Aug 2024 | US$883.3b | US$113.2b | -US$35,828,678,074.72 | 23.2x | -24.7x | 7.8x |
| Thu, 18 Jul 2024 | US$1.2t | US$164.5b | -US$28,053,331,413.34 | 29.4x | -43.2x | 7.4x |
| Sat, 15 Jun 2024 | US$1.2t | US$164.4b | -US$28,065,533,148.41 | 27.3x | -41.3x | 7.1x |
| Mon, 13 May 2024 | US$1.1t | US$164.6b | -US$26,961,785,793.98 | 23.3x | -41.2x | 6.7x |
| Wed, 10 Apr 2024 | US$1.1t | US$164.4b | -US$23,371,088,407.86 | 21.5x | -48.3x | 6.9x |
| Fri, 08 Mar 2024 | US$1.2t | US$167.5b | -US$21,885,421,990.22 | 18.8x | -54.5x | 7.1x |
| Sun, 04 Feb 2024 | US$1.4t | US$203.9b | -US$24,418,168,728.00 | 19.2x | -58.9x | 7.1x |
| Tue, 02 Jan 2024 | US$1.4t | US$204.9b | -US$22,203,182,413.00 | 19.8x | -62.5x | 6.8x |
| Thu, 30 Nov 2023 | US$1.2t | US$204.8b | -US$22,009,160,710.00 | 18.1x | -55.4x | 6x |
| Sat, 28 Oct 2023 | US$1.2t | US$206.6b | -US$15,166,070,486.00 | 16.3x | -77.7x | 5.7x |
| Mon, 25 Sep 2023 | US$1.3t | US$207.5b | -US$12,879,333,723.00 | 17.1x | -97.9x | 6.1x |
| Wed, 23 Aug 2023 | US$1.3t | US$207.6b | -US$12,453,450,426.00 | 17.4x | -102.7x | 6.2x |
| Fri, 21 Jul 2023 | US$1.1t | US$186.5b | -US$16,008,267,080.00 | 12.7x | -71.5x | 6.1x |
| Sun, 18 Jun 2023 | US$1.2t | US$186.3b | -US$16,045,332,946.00 | 12.1x | -72.3x | 6.2x |
| Tue, 16 May 2023 | US$1.2t | US$191.8b | -US$12,215,533,598.00 | 13.8x | -95.7x | 6.1x |
| Thu, 13 Apr 2023 | US$1.2t | US$198.5b | -US$3,250,698,650.00 | 14x | -357.1x | 5.8x |
| Sat, 11 Mar 2023 | US$1.1t | US$199.3b | -US$4,751,094,936.00 | 14.9x | -230.3x | 5.5x |
| Mon, 06 Feb 2023 | US$1.2t | US$202.3b | US$1.9b | 16.3x | 624.5x | 5.7x |
| Wed, 04 Jan 2023 | US$1.1t | US$203.2b | US$1.6b | 14.3x | 722.7x | 5.6x |
| Fri, 02 Dec 2022 | US$1.2t | US$202.6b | US$1.4b | 15.2x | 814.9x | 5.7x |
| Sun, 30 Oct 2022 | US$1.1t | US$205.9b | US$7.4b | 14.3x | 148.7x | 5.3x |
| Tue, 27 Sep 2022 | US$999.8b | US$205.8b | US$5.5b | 13.8x | 181.9x | 4.9x |
| Thu, 25 Aug 2022 | US$1.1t | US$206.2b | US$7.3b | 16x | 147.3x | 5.2x |
| Sat, 23 Jul 2022 | US$1.1t | US$211.4b | US$11.3b | 16.6x | 95.9x | 5.1x |
Price to Earnings Ratio
95.9x
Current Industry PE
- Investors are relatively neutral on the American Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 9.7% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | 0.15% | |
| Healthcare | -1.49% | |
| Biotech | 0.37% | |
| Biotech | 0.37% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONC BeOne Medicines | US$269.70 | 10.3% +US$3.0b | 76.4% | PS7.7x | |
| RYTM Rhythm Pharmaceuticals | US$89.36 | 37.2% +US$1.7b | 65.8% | PS42.9x | |
| MTSR Metsera | US$42.98 | 42.7% +US$1.4b | n/a | PB8.9x | |
| INSM Insmed | US$102.87 | 7.0% +US$1.3b | 31.9% | PS51.3x | |
| SMMT Summit Therapeutics | US$24.36 | 6.0% +US$1.0b | 167.1% | PB52.5x |